| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1000195223 |
| P356 | DOI | 10.1007/S10384-012-0139-2 |
| P698 | PubMed publication ID | 22581454 |
| P2093 | author name string | Kenji Kashiwagi | |
| P2860 | cites work | Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension | Q43758824 |
| Comparison of topical travoprost eye drops given once daily and timolol 0.5% given twice daily in patients with open-angle glaucoma or ocular hypertension | Q43801480 | ||
| Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure | Q44414154 | ||
| A Novel Grading Method for Superficial Punctate Keratopathy Magnitude and Its Correlation With Corneal Epithelial Permeability | Q44650379 | ||
| The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution | Q46576934 | ||
| Spirometry for patients prescribed topical beta-blockers. | Q51719613 | ||
| Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). | Q31134303 | ||
| Bronchial reactivity in healthy individuals undergoing long-term topical treatment with beta-blockers | Q33210746 | ||
| Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy | Q33867915 | ||
| Changes in trend of newly prescribed anti-glaucoma medications in recent nine years in a Japanese local community | Q33886940 | ||
| Travoprost 0.004%/timolol 0.5%-fixed combination with and without benzalkonium chloride: a prospective, randomized, doubled-masked comparison of safety and efficacy | Q35227003 | ||
| Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients | Q35315104 | ||
| Resting pulse rates in a glaucoma clinic: the effect of topical and systemic beta-blocker usage | Q36085655 | ||
| Travoprost/timolol | Q36575744 | ||
| Travoprost 0.004%/timolol 0.5% fixed combination | Q36758344 | ||
| Travoprost/timolol fixed combination | Q37123433 | ||
| Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project | Q37243715 | ||
| Persistence of patients receiving topical glaucoma monotherapy in an Asian population | Q37827285 | ||
| Travoprost/timolol fixed combination in the management of open-angle glaucoma: a clinical review | Q37831356 | ||
| Balancing efficacy and tolerability of prostaglandin analogues and prostaglandin-timolol fixed combinations in primary open-angle glaucoma. | Q37923962 | ||
| Effects of antiglaucoma drugs on the ocular surface in rabbits: a fixed-combination drug versus two concomitant drugs | Q38470550 | ||
| Systemic adverse effects of topical ophthalmic agents. Implications for older patients | Q41634574 | ||
| Determinants of adherence to glaucoma medical therapy in a long-term patient population | Q42615263 | ||
| Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. | Q42628471 | ||
| Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial | Q42675463 | ||
| Safety and efficacy of monotherapy change to fixed combination (travoprost 0.004%/timolol 0.5%) in 6 months follow up period. | Q42727853 | ||
| Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells. | Q42794581 | ||
| Effects of brimonidine 0.2%-timolol 0.5% fixed-combination therapy for glaucoma | Q42835956 | ||
| Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells | Q42865951 | ||
| P433 | issue | 4 | |
| P921 | main subject | latanoprost | Q634959 |
| P304 | page(s) | 339-345 | |
| P577 | publication date | 2012-05-15 | |
| P1433 | published in | Japanese Journal of Ophthalmology | Q15752406 |
| P1476 | title | Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy | |
| P478 | volume | 56 |
| Q58700892 | Changes in adherence and associated factors among patients on newly introduced prostaglandin analog and timolol fixed-combination therapy |
| Q35950506 | Comparison between bimatoprost and latanoprost-timolol fixed combination for efficacy and safety after switching patients from latanoprost |
| Q42965893 | Effect on intraocular pressure of switching from latanoprost and travoprost monotherapy to timolol fixed combinations in patients with normal-tension glaucoma |
| Q36709208 | Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost |
| Q55192535 | Efficacy and Safety of Switching Prostaglandin Analog Monotherapy to Tafluprost/Timolol Fixed-Combination Therapy. |
| Q42636880 | Persistence with topical glaucoma therapy among newly diagnosed Japanese patients |
| Q85646322 | Recovery from deepening of the upper eyelid sulcus after switching from bimatoprost to latanoprost |
| Q41015854 | The signs of ocular-surface disorders after switching from latanoprost to tafluprost/timolol fixed combination: a prospective study |
Search more.